Neil Rabin
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Genetics top 5%
- Surgery
- Co-authors
- Kwee YongChara KyriakouAmit NathwaniArnold PizzeyRakesh PopatShirley D’SaAli RismaniCharalampia Kyriakou
- Topics
- Multiple Myeloma Research and Treatments (58 papers)Cancer Treatment and Pharmacology (18 papers)Protein Degradation and Inhibitors (18 papers)
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United KingdomUnited StatesGreece
In The Last Decade
Neil Rabin
60 papers receiving 777 citations
Peers
Comparison fields: 5 of 68
- Hematology 409
- Molecular Biology 396
- Oncology 321
- Genetics 195
- Surgery 83
Countries citing papers authored by Neil Rabin
This map shows the geographic impact of Neil Rabin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Rabin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Rabin more than expected).
Fields of papers citing papers by Neil Rabin
This network shows the impact of papers produced by Neil Rabin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Rabin. The network helps show where Neil Rabin may publish in the future.
Co-authorship network of co-authors of Neil Rabin
This figure shows the co-authorship network connecting the top 25 collaborators of Neil Rabin. A scholar is included among the top collaborators of Neil Rabin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Rabin. Neil Rabin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 15 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 12 | |
| 11 | 28 | |
| 12 | 7 | |
| 13 | 18 | |
| 14 | 4 | |
| 15 | 42 | |
| 16 | 36 | |
| 17 | REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA | 5 |
| 18 | 46 | |
| 19 | An open-label, randomised phase 3 study of daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM): POLLUX | 11 |
| 20 | 14 |
About Neil Rabin
Neil Rabin is a scholar working on Hematology, Oncology and Genetics, having authored 72 papers that have together received 788 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (58 papers), Cancer Treatment and Pharmacology (18 papers) and Protein Degradation and Inhibitors (18 papers). The work is most often cited by research in Hematology (409 citations), Genetics (195 citations) and Oncology (321 citations). Neil Rabin has collaborated with scholars based in United Kingdom, United States and Greece. Frequent co-authors include Kwee Yong, Chara Kyriakou, Amit Nathwani, Arnold Pizzey, Rakesh Popat, Shirley D’Sa, Ali Rismani, Charalampia Kyriakou, Νικόλαος Δικαίος and Margaret Hall‐Craggs. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.